Latest Breaking News On - Mo qatanani - Page 1 : comparemela.com

Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity

22.05.2024 - Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental . Seite 1

New yorkUnited statesJay backstromMo qatananiAmerican diabetes associationRock announces initiationNew preclinical data supportingChief scientific officerScholar rockInvestor eventChief executive officerScientific sessions

Q2 2024 EPS Estimates for Scholar Rock Holding Co. Decreased by Analyst (NASDAQ:SRRK)

Q2 2024 EPS Estimates for Scholar Rock Holding Co. Decreased by Analyst (NASDAQ:SRRK)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesJayt backstromMo qatananiPiper sandlerBarclays plcScholar rock holding corporationPolar capital holdings plcScholar rock company profileScholar rock holding coSecurities exchange commissionJennison associatesAlps advisors incScholar rock holdingFree reportScholar rockGet free report

Scholar Rock (NASDAQ:SRRK) Receives "Buy" Rating from HC Wainwright

Scholar Rock (NASDAQ:SRRK) Receives "Buy" Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerRaymond jamesMo qatananiJayt backstromScholar rock holding corporationBoard of administration florida retirement systemChina universal asset management coSg americas securitiesSecurities exchange commissionSilverarc capital managementScholar rockFree reportRock stock downGet free reportExchange commission

Scholar Rock (NASDAQ:SRRK) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Scholar Rock (NASDAQ:SRRK) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerMo qatananiRaymond jamesJayt backstromScholar rock holding corporationSecurities exchange commissionScholar rockGet free reportRock stock downExchange commissionRock holding corporationScholar rock daily

Scholar Rock (NASDAQ:SRRK) Releases Earnings Results, Misses Expectations By $0.11 EPS

Scholar Rock (NASDAQ:SRRK) Releases Earnings Results, Misses Expectations By $0.11 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesJayt backstromPiper sandlerMo qatananiSecurities exchange commissionScholar rock holding corporationScholar rock company profileScholar rockGet free reportRock stock downExchange commissionRock holding corporationScholar rock daily